HOME >> BIOLOGY >> NEWS
Insight into natural cholesterol control suggests novel cholesterol-lowering therapy

ld, in turn, control the rate of cholesterol production.

"In addition to the biological significance, the findings have important clinical implications for cholesterol control," he said.

Cholesterol-lowering statins--taken by an estimated 10 million people each day to protect against coronary artery disease and reduce the incidence of heart attacks--limit cholesterol synthesis by inhibiting reductase function, he said. As a result, cells take up more cholesterol from the bloodstream, lowering its concentration there.

However, inhibition of reductase function by statins also limits the availability of regulatory intermediates that govern reductase activity, contributing to a major increase in active reductase that becomes progressively harder to control, according to the researchers. The new findings suggest that drugs that mimic lanosterol--given along with statins--may improve the drugs' long-term ability to lower cholesterol by stimulating reductase degradation.


'"/>

Contact: Heidi Hardman
hhardman@cell.com
1-617-397-2979
Cell Press
15-Mar-2005


Page: 1 2

Related biology news :

1. Insights into osteosarcoma in cats and dogs may improve palliative care
2. Insight into evolution of adaptive immunity boosted by sea urchin genome sequencing
3. Insights into honey bee sex gene could bring sweet success in breeding
4. Insights into activity-dependent neuronal growth through RSRF-supported research
5. Symposium Environmental Change in Siberia -- Insights From Earth Observation and Modeling
6. Yale technology spins out varicose vein device company: Vascular Insights, LLC
7. Insight into our sight: A new view on the evolution of the eye lens
8. Insight into the processes of positive and negative learners
9. Insight into JAK/STAT
10. Insight into cell metabolism will help interpret PETs, MRIs
11. Insight into DNAs weakest links may yield clues to cancer biology

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2019)... , ... February 04, 2019 , ... ... new Explorer™ story which provides insights to help individuals understand how the gut ... cardiovascular wellness. , After individuals eat foods that contain choline and L-carnitine, ...
(Date:2/2/2019)... ... January 31, 2019 , ... Aperio ... customizable clinical research services across multiple therapeutic areas, announced an Innovation Partner ... life science entrepreneurs in the Research Triangle region of North Carolina. ...
(Date:1/25/2019)... ... January 24, 2019 , ... GrowthZone, Inc., ... Survey. The report indicates membership growth in some sectors and decreasing membership among ... received responses from over 500 association professionals across North America. , “This ...
Breaking Biology News(10 mins):
(Date:1/15/2019)... ... 2019 , ... Personalized treatment plans may extend life expectancy for early-stage kidney ... study published in the journal Radiology. , Kidney, or renal, tumors are often ... procedure in which the tumor and part of the kidney are removed. However, some ...
(Date:1/11/2019)... ... ... Drawing on over 22 years of software development expertise, the live webinar ... the key lessons that have driven customer satisfaction with their eClinical suite. Explore the ... how to ensure that you continue to be able to take advantage of the ...
(Date:1/10/2019)... ... 2019 , ... VGI Medical was founded in 2007 based on an invention ... the market including VerteLoc, CerLoc, SiJoin and VerteLP. The VerteLoc and CerLoc systems are ... dual geometric design to limit motion of the affected spinal segment. Applying the principles ...
(Date:1/7/2019)... (PRWEB) , ... January 07, 2019 , ... ... 1 clinical trials of its Parkinson's Disease drug candidate, code-named "KM-819." KM-819 ... Parkinson's Disease. The trial took place in South Korea. , This Phase ...
Breaking Biology Technology:
Cached News: